Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.99B | 13.95B | 13.60B | 13.34B | 12.36B | 11.60B | Gross Profit |
6.06B | 6.02B | 5.94B | 5.43B | 4.66B | 4.28B | EBIT |
1.26B | 1.07B | 1.12B | 800.00M | 531.01M | 323.49M | EBITDA |
2.23B | 2.19B | 2.17B | 1.81B | 1.77B | 1.57B | Net Income Common Stockholders |
956.00M | 782.00M | 1.02B | 833.00M | 523.00M | 369.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.41B | 6.40B | 6.71B | 5.78B | 4.45B | 3.63B | Total Assets |
29.77B | 29.47B | 29.24B | 26.64B | 25.73B | 25.29B | Total Debt |
940.00M | 925.00M | 909.00M | 941.00M | 979.07M | 1.03B | Net Debt |
-5.47B | -5.47B | -5.78B | -4.84B | -3.47B | -2.60B | Total Liabilities |
7.94B | 7.20B | 7.89B | 7.13B | 6.96B | 6.79B | Stockholders Equity |
21.82B | 22.26B | 21.35B | 19.49B | 18.75B | 18.49B |
Cash Flow | Free Cash Flow | ||||
0.00 | 501.00M | 1.43B | 1.49B | 1.12B | 348.33M | Operating Cash Flow |
0.00 | 1.40B | 1.99B | 1.73B | 1.58B | 1.72B | Investing Cash Flow |
0.00 | -1.12B | -520.00M | -103.00M | -457.15M | -1.02B | Financing Cash Flow |
0.00 | -622.00M | -672.00M | -369.00M | -363.55M | -395.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥7.78B | 9.36 | 4.72% | 2.53% | -20.16% | ||
75 Outperform | ¥21.01B | 11.52 | 4.39% | 2.95% | -52.19% | ||
72 Outperform | ¥42.01B | 11.90 | 3.28% | 9.57% | -20.71% | ||
68 Neutral | ¥6.84B | 9.26 | 2.22% | 2.20% | 30.07% | ||
66 Neutral | €26.94B | 6.11 | 4.96% | 2.64% | -9.06% | 4.05% | |
51 Neutral | $2.04B | -1.26 | -21.09% | 3.98% | 2.91% | -30.49% | |
49 Neutral | ¥3.92B | 109.34 | ― | 6.26% | -31.63% |